MSB 2.91% $1.06 mesoblast limited

Cell Therapy News/Articles, page-11608

  1. 7,843 Posts.
    lightbulb Created with Sketch. 1345
    The inability to be critical whatsoever of a company that time and time again fails to accomplish its goals is a very odd behaviour.

    You can still support and invest in a company yet disagree with some of its methods.
    There's nothing wrong with reflecting on how they could have done things differently.

    It's a great way of preventing these things from happening in the future.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.